{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:33:18Z","timestamp":1761823998358,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402901","81673464","81373441"],"award-info":[{"award-number":["81402901","81673464","81373441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.prp.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,10]],"date-time":"2018-06-10T09:41:01Z","timestamp":1528623661000},"page":"1123-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical features and the molecular biomarkers of olfactory neuroblastoma"],"prefix":"10.1016","volume":"214","author":[{"given":"Xiaolin","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2018.06.002_bib0005","first-page":"410","article-title":"L\u2019esthesioneuroepitheliome olfactif","volume":"13","author":"Berger","year":"1924","journal-title":"Bull. Assoc. Franc Etude Cancer"},{"key":"10.1016\/j.prp.2018.06.002_bib0010","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archotol.133.3.276","article-title":"Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors","volume":"133","author":"Jethanamest","year":"2007","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.prp.2018.06.002_bib0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/0194599811416752","article-title":"Therapy and prognosis of intracranial invasive olfactory neuroblastoma","volume":"145","author":"Jiang","year":"2011","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.prp.2018.06.002_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1535-6108(03)00216-2","article-title":"Cell signaling and cancer","volume":"4","author":"Martin","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2018.06.002_bib0025","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1002\/jcp.24065","article-title":"PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics","volume":"227","author":"Mahajan","year":"2012","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.prp.2018.06.002_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2018.06.002_bib0035","first-page":"136","article-title":"Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors","volume":"1845","author":"Siveen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.prp.2018.06.002_bib0040","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1158\/1078-0432.CCR-08-0333","article-title":"Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway","volume":"14","author":"Sebolt-Leopold","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2018.06.002_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-8722-6-36","article-title":"Novel agents for chronic lymphocytic leukemia","volume":"6","author":"Wu","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2018.06.002_bib0050","doi-asserted-by":"crossref","first-page":"19897","DOI":"10.18632\/oncotarget.7658","article-title":"ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2018.06.002_bib0055","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.coph.2012.06.008","article-title":"Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease","volume":"12","author":"Kontzias","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.prp.2018.06.002_bib0060","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L","article-title":"Olfactory neuroblastoma. A clinical analysis of 17 cases","volume":"37","author":"Kadish","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2018.06.002_bib0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0360-3016(93)90457-7","article-title":"Esthesioneuroblastoma: the role of adjuvant radiation therapy","volume":"27","author":"Foote","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.prp.2018.06.002_bib0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1288\/00005537-199208000-00001","article-title":"Esthesioneuroblastoma: the UCLA experience 1970-1990","volume":"102","author":"Dulguerov","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.prp.2018.06.002_bib0075","series-title":"Atlas of Tumor Pathology","first-page":"240","article-title":"Tumors of the upper respiratory tract and ear","author":"Hymas","year":"1988"},{"key":"10.1016\/j.prp.2018.06.002_bib0080","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1097\/SCS.0b013e3182a41c52","article-title":"Syndrome of inappropriate antidiuretic hormone secretion associated with olfactory neuroblastoma","volume":"24","author":"Yumusakhuylu","year":"2013","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.prp.2018.06.002_bib0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1756-9966-31-30","article-title":"Prognostic value of RKIP and p-ERK in gastric cancer","volume":"31","author":"Fujimori","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2018.06.002_bib0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12105-009-0125-2","volume":"3","author":"Thompson","year":"2009","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.prp.2018.06.002_bib0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.otohns.2007.12.038","article-title":"Esthesioneuroblastoma: 25-year experience at a single institution","volume":"138","author":"Zafereo","year":"2008","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.prp.2018.06.002_bib0100","article-title":"Long-term prognostic analysis after endoscopic endonasal surgery for olfactory neuroblastoma: a retrospective study of 13 cases","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2018.06.002_bib0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.otohns.2003.10.010","article-title":"Olfactory neuroblastoma: the university of Erlangen-Nuremberg experience 1975-2000","volume":"130","author":"Constantinidis","year":"2004","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.prp.2018.06.002_bib0110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1097-0347(200009)22:6<550::AID-HED2>3.0.CO;2-0","article-title":"Esthesioneuroblastoma: the Johns Hopkins experience","volume":"22","author":"Resto","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.prp.2018.06.002_bib0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hed.20127","article-title":"Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center","volume":"27","author":"Diaz","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.prp.2018.06.002_bib0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.prp.2018.06.002_bib0125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.prp.2018.06.002_bib0130","first-page":"3312","article-title":"Phosphorylation status of Akt and caspase-9 in gastric and colorectal carcinomas","volume":"7","author":"Sangawa","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2018.06.002_bib0135","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.3748\/wjg.v18.i45.6577","article-title":"Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer","volume":"18","author":"Nobuoka","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2018.06.002_bib0140","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3892\/ol.2012.930","article-title":"Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma","volume":"4","author":"Li","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2018.06.002_bib0145","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-08-2138","article-title":"Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer","volume":"15","author":"Yu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2018.06.002_bib0150","unstructured":"J. McCain, The MAPK (ERK) Pathway: Investigational Combinations for the Treatment Of BRAF-Mutated Metastatic Melanoma, P. T. 38 (2013) 96-108."},{"key":"10.1016\/j.prp.2018.06.002_bib0155","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don\u2019t know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.prp.2018.06.002_bib0160","doi-asserted-by":"crossref","first-page":"07","DOI":"10.2174\/156800906776056491","article-title":"Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs","volume":"6","author":"Klampfer","year":"2006","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.prp.2018.06.002_bib0165","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/0008-5472.CAN-05-3757","article-title":"Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor","volume":"66","author":"Alvarez","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2018.06.002_bib0170","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/jcb.23440","article-title":"Helicobacter pylori CagA inhibits the expression of Runx3 via Src\/MEK\/ERK and p38 MAPK pathways in gastric epithelial cell","volume":"113","author":"Liu","year":"2012","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.prp.2018.06.002_bib0175","doi-asserted-by":"crossref","first-page":"14498","DOI":"10.1074\/jbc.M010093200","article-title":"Akt\/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells","volume":"276","author":"Sheng","year":"2001","journal-title":"J. Biol. Chem."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818304977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818304977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:36:54Z","timestamp":1759732614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818304977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0344033818304977"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2018.06.002","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and the molecular biomarkers of olfactory neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}